James Neal - Insider Trading & Ownership

Location
2910 Seventh Street, Berkeley, CA
Summary
The estimated net worth of James Neal is at least $711K dollars as of October 3, 2025. James Neal is the CEO, Director of XOMA Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $637K. James Neal is the Director of Akari Therapeutics Plc and owns shares of Akari Therapeutics Plc (AKTX) stock worth about $70K. James Neal is the Director of PALISADE BIO, INC. and owns shares of PALISADE BIO, INC. (PALI) stock worth about $4.76K.
Signature
/s/ James Neal by John J. Wolfel, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of James Neal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XOMA, XOMAO XOMA Royalty Corp CEO, Director $637K Jul 15, 2022
AKTX Akari Therapeutics Plc Director $70K Mar 20, 2025
PALI PALISADE BIO, INC. Director $4.76K Feb 9, 2024
PKBO Peak Bio, Inc. Director $0 Nov 14, 2024
MTRY Monterey Innovation Acquisition Corp Director Sep 30, 2021
PCSA Processa Pharmaceuticals, Inc. Director Oct 1, 2025

Insider Transactions Reported by James Neal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.